http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-201301300-A2

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L29-269
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K6-00
filingDate 2013-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2014-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EA-201301300-A2
titleOfInvention PHARMACEUTICAL COMPOSITION IN THE FORM OF ORAL SUSPENSION THAT CONTAINS THE FLAVONOID FRACTURE AND XANTAN GUM
abstract The pharmaceutical composition is in the form of an oral suspension that contains diosmin and xanthan gum. The use of the pharmaceutical composition according to the invention in the treatment of venous insufficiency.
priorityDate 2012-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426067844
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281613
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154496039
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433321579

Total number of triples: 19.